Population-based epidemiological study of neurological diseases in Taiwan: I. Creutzfeldt-Jakob disease and multiple sclerosis

Neuroepidemiology

Volumn 33, Issue 3, 2009, Pages 247-253

  Lai, Chien Hsu ^a   Tseng, Hung Fu ^b  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b KAISER PERMANENTE   (United States)

Author keywords

Creutzfeldt Jakob disease; Medical expenses; Multiple sclerosis; Taiwan, incidence, prevalence

Indexed keywords

ADULT; AGED; ARTICLE; COST OF ILLNESS; CREUTZFELDT JAKOB DISEASE; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PREVALENCE; TAIWAN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CREUTZFELDT-JAKOB SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; POPULATION SURVEILLANCE; TAIWAN; YOUNG ADULT;

EID: 67651226883     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000229779     Document Type: Article

References (35)

1. Lai CH, Tseng HF: Epidemiology and medical expenses of motor neuron diseases in Taiwan. Neuroepidemiology 2008; 31: 159-166.
2. Woung LC, Lin CH, Tsai CY, Tsai MT, Jou JR, Chou P: Optic neuritis among Nation - al Health Insurance enrollees in Taiwan, 2000-2004. Neuroepidemiology 2007; 29: 250-254.
3. Tseng HF, Tan HF, Chang CK: Use of National Health Insurance database to evaluate the impact of public varicella vaccination program on burden of varicella in Taiwan. Vaccine 2006; 24: 5341-5348.
4. Henry G, Brown JML: Creutzfeldt-Jakob disease. 2008. http://www.uptodate. com.
5. Collinge J: Variant Creutzfeldt-Jakob disease. Lancet 1999; 354: 317-323.
6. Brown P, Preece MA, Will RG: 'Friendly fire' in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 1992; 340: 24-27.
7. Frasier SD: The not-so-good old days: working with pituitary growth hormone in North America, 1956 to 1985. J Pediatr 1997; 131: S1-S4.
8. Lewis AM, Yu M, DeArmond SJ, Dillon WP, Miller BL, Geschwind MD: Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal imaging. Arch Neurol 2006; 63: 288-290. (Pubitemid 43261744)
9. Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts - Japan, 1978-2008. MMWR Morb Mortal Wkly Rep 2008; 57: 1152-1154.
10. Defebvre L, Destee A, Caron J, Ruchoux MM, Wurtz A, Remy J: Creutzfeldt-Jakob disease after an embolization of intercostal arteries with cadaveric dura mater suggesting a systemic transmission of the prion agent. Neurology 1997; 48: 1470-1471. (Pubitemid 27240592)
11. Allan B, Tuft S: Transmission of Creutzfeldt- Jakob disease in corneal grafts. BMJ 1997; 315: 1553-1554. (Pubitemid 27522391)
12. Heckmann JG, Lang CJ, Petruch F, Druschky A, Erb C, Brown P, Neundorfer B: Transmission of Creutzfeldt-Jakob disease via a corneal transplant. J Neurol Neurosurg Psychiatry 1997; 63: 388-390. (Pubitemid 27412386)
13. Creange A, Gray F, Cesaro P, Adle-Biassette H, Duvoux C, Cherqui D, Bell J, Parchi P, Gambetti P, Degos JD: Creutzfeldt-Jakob disease after liver transplantation. Ann Neurol 1995; 38: 269-272.
14. Johnson RT, Gibbs CJ Jr: Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 1998; 339: 1994-2004. (Pubitemid 29024133)
15. Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, Klug GM, Sutcliffe T, Giulivi A, Alperovitch A, Delasnerie-Laupretre N, Brandel JP, Poser S, Kretzschmar H, Rietveld I, Mitrova E, Cuesta J de P, Martinez- Martin P, Glatzel M, Aguzzi A, Knight R, Ward H, Pocchiari M, van Duijn CM, Will RG, Zerr I: Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 2005; 64: 1586-1591.
16. Olek MJ: Epidemiology, risk factors, and clinical features of multiple sclerosis in adults. 2008. http://www.uptodate.com.
17. Hung TP, Landsborough D, Hsi MS: Multiple sclerosis amongst Chinese in Taiwan. J Neurol Sci 1976; 27: 459-484.
18. Tsai CP, Yuan CL, Yu HY, Chen C, Guo YC, Shan DE: Multiple sclerosis in Taiwan. J Chin Med Assoc 2004; 67: 500-505.
19. Gibbons RV, Holman RC, Belay ED, Schonberger LB: Creutzfeldt-Jakob disease in the United States: 1979-1998. JAMA 2000; 284: 2322-2323.
20. Elsaadany S, Semenciw R, Ricketts M, Mao Y, Giulivi A: Epidemiological study of Creutzfeldt-Jakob disease death certificates in Canada, 1979-2001. Neuroepidemiology 2005; 24: 15-21.
21. Doi Y, Yokoyama T, Sakai M, Nakamura Y, Tango T, Takahashi K: Spatial clusters of Creutzfeldt-Jakob disease mortality in Japan between 1995 and 2004. Neuroepidemiology 2008; 30: 222-228.
22. Maddox RA, Holman RC, Belay ED, Cheek JE, Yorita KL, Schonberger LB: Creutzfeldt- Jakob disease among American Indians and Alaska Natives in the United States. Neurology 2006; 66: 439-441. (Pubitemid 43739955)
23. Gelpi E, Heinzl H, Hoftberger R, Unterberger U, Strobel T, Voigtlander T, Drobna E, Jarius C, Lang S, Waldhor T, Bernheimer H, Budka H: Creutzfeldt-Jakob disease in Austria: an autopsy-controlled study. Neuroepidemiology 2008; 30: 215-221. (Pubitemid 351871651)
24. Holman RC, Khan AS, Kent J, Strine TW, Schonberger LB: Epidemiology of Creutzfeldt- Jakob disease in the United States, 1979-1990: analysis of national mortality data. Neuroepidemiology 1995; 14: 174-181.
25. Cheng Q, Miao L, Zhang J, Ding SJ, Liu ZG, Wang X, Sun XJ, Zhao ZX, Song YJ, Ding XY, Guo ZL, Yang Y, Chen SD, Jiang GX, Fredrikson S: A population-based survey of multiple sclerosis in Shanghai, China. Neurology 2007; 68: 1495-1500. (Pubitemid 46685920)
26. Kira J: Multiple sclerosis in the Japanese population. Lancet Neurol 2003; 2: 117-127.
27. Yu YL, Woo E, Hawkins BR, Ho HC, Huang CY: Multiple sclerosis amongst Chinese in Hong Kong. Brain 1989; 112: 1445-1467. (Pubitemid 20024214)
28. al-Din AS, Khogali M, Poser CM, al-Nassar KE, Shakir R, Hussain J, Behbahani K, Chadha G: Epidemiology of multiple sclerosis in Arabs in Kuwait: a comparative study between Kuwaitis and Palestinians. J Neurol Sci 1990; 100: 137-141.
29. al-Din AS, el-Khateeb M, Kurdi A, Mubaidin A, Wriekat A, al-Shehab A, Khalil RW: Multiple sclerosis in Arabs in Jordan. J Neurol Sci 1995; 131: 144-149.
30. Itoh T, Aizawa H, Hashimoto K, Yoshida K, Kimura T, Katayama T, Koyama S, Yahara O, Kikuchi K: Prevalence of multiple sclerosis in Asahikawa, a city in northern Japan. J Neurol Sci 2003; 214: 7-9. (Pubitemid 37100974)
31. Alshubaili AF, Alramzy K, Ayyad YM, Gerish Y: Epidemiology of multiple sclerosis in Kuwait: new trends in incidence and prevalence. Eur Neurol 2005; 53: 125-131. (Pubitemid 40864303)
32. El-Salem K, Al-Shimmery E, Horany K, Al- Refai A, Al-Hayk K, Khader Y: Multiple sclerosis in Jordan: a clinical and epidemiological study. J Neurol 2006; 253: 1210-1216. (Pubitemid 44511480)
33. Houzen H, Niino M, Hata D, Nakano F, Kikuchi S, Fukazawa T, Sasaki H: Increasing prevalence and incidence of multiple sclerosis in northern Japan. Mult Scler 2008; 14: 887-892.
34. Lau KK, Wong WW, Sheng B, Yu IT, Fung BH, Li HL, Ma KF, Wong LK, Li PC: The clinical course of multiple sclerosis patients in Hong Kong. J Neurol Sci 2008; 268: 78-82.
35. Kira J: Epidemiology of multiple sclerosis in Japanese: with special reference to opticospinal multiple sclerosis (in Japanese). Rinsho Shinkeigaku 2006; 46: 859-862. (Pubitemid 46623869)